Ticker
ZYMECompany Name
ZYMEWORKS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 408.38M | $ 98.25M | 24.06% |
3/31/2025 | $ 425.52M | $ 76.2M | 17.91% |
12/31/2024 | $ 463.09M | $ 66.1M | 14.27% |
9/30/2024 | $ 487.15M | $ 122.36M | 25.12% |
6/30/2024 | $ 515.63M | $ 70.96M | 13.76% |
3/31/2024 | $ 553.75M | $ 114.81M | 20.73% |
12/31/2023 | $ 580.88M | $ 157.56M | 27.12% |
9/30/2023 | $ 556.37M | $ 94.33M | 16.96% |
6/30/2023 | $ 602.05M | $ 142.1M | 23.6% |
3/31/2023 | $ 600.74M | $ 181.58M | 30.23% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for ZYMEWORKS INC is calculated as follows: CashnEq [ $ 244.12M ] / Assets [ $ 571.72M ]
(=) Cash to Assets [ 42.7% ]
Minimum
Jun 30, 2024
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.95K |
---|---|
min | 0% |
max | 40.92% |
average | 9.84% |
median | 6.44% |
std | 9.62% |